middle.news
Anatara Takes Anti-Obesity Compound AOC Toward Manufacturing
10:58am on Tuesday 13th of October, 2026 AEDT
•
Healthcare
Read Story
Anatara Takes Anti-Obesity Compound AOC Toward Manufacturing
10:58am on Tuesday 13th of October, 2026 AEDT
Key Points
AOC demonstration batch planned at approximately 10,000 capsules
Further pre-clinical work and immediate clinical trial ruled unnecessary by Anatara
Mouse studies showed reduced weight regain and perigonadal fat, but GLP-1 mechanism data remained inconclusive
September quarter-end cash rose to $551,000 after a $318,402 R&D rebate
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Anatara Lifesciences (ASX:ANR)
OPEN ARTICLE